Literature DB >> 24574711

Core promoter: a critical region where the hepatitis B virus makes decisions.

Jorge Quarleri1.   

Abstract

The core promoter (CP) of the viral genome plays an important role for hepatitis B virus (HBV) replication as it directs initiation of transcription for the synthesis of both the precore and pregenomic (pg) RNAs. The CP consists of the upper regulatory region and the basal core promoter (BCP). The CP overlaps with the 3'-end of the X open reading frames and the 5'-end of the precore region, and contains cis-acting elements that can independently direct transcription of the precore mRNA and pgRNA. Its transcription regulation is under strict control of viral and cellular factors. Even though this regulatory region exhibits high sequence conservation, when variations appear, they may contribute to the persistence of HBV within the host, leading to chronic infection and cirrhosis, and eventually, hepatocellular carcinoma. Among CP sequence variations, those occurring at BCP may dysregulate viral gene expression with emphasis in the hepatitis B e antigen, and contribute to disease progression. In this review these molecular aspects and pathologic topics of core promoter are deeply evaluated.

Entities:  

Keywords:  Basal core promoter; Core promoter; Hepatitis B virus; Transcription regulation; Variants

Mesh:

Substances:

Year:  2014        PMID: 24574711      PMCID: PMC3923017          DOI: 10.3748/wjg.v20.i2.425

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  78 in total

1.  Transcription repression of human hepatitis B virus genes by negative regulatory element-binding protein/SON.

Authors:  C T Sun; W Y Lo; I H Wang; Y H Lo; S R Shiou; C K Lai; L P Ting
Journal:  J Biol Chem       Date:  2001-04-16       Impact factor: 5.157

2.  Hepatitis B virus harboring nucleotide deletions in the core promoter region and genotype B correlate with low viral replication activity in anti-HBe positive carriers.

Authors:  K S Li; T Yamashiro; A Sumie; H Terao; K Mifune; A Nishizono
Journal:  J Clin Virol       Date:  2001-12       Impact factor: 3.168

3.  Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity.

Authors:  Yanli Qin; Xiaoli Tang; Tamako Garcia; Munira Hussain; Jiming Zhang; Anna Lok; Jack Wands; Jisu Li; Shuping Tong
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

Review 4.  The core promoter of hepatitis B virus.

Authors:  A Kramvis; M C Kew
Journal:  J Viral Hepat       Date:  1999-11       Impact factor: 3.728

5.  Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

Authors:  K Moriyama; H Okamoto; F Tsuda; M Mayumi
Journal:  Virology       Date:  1996-12-15       Impact factor: 3.616

6.  Features and clinical implications of hepatitis B virus genotypes and mutations in basal core promoter/precore region in 507 Chinese patients with acute and chronic hepatitis B.

Authors:  Yan Liu; Yanwei Zhong; Zhengsheng Zou; Zhihui Xu; Baosen Li; Xiaoqiang Ren; Siyu Bai; Lin Wang; Xiaodong Li; Jiuzeng Dai; Yao Wang; Panyong Mao; Dongping Xu
Journal:  J Clin Virol       Date:  2010-01-15       Impact factor: 3.168

7.  The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection.

Authors:  K Takahashi; K Aoyama; N Ohno; K Iwata; Y Akahane; K Baba; H Yoshizawa; S Mishiro
Journal:  J Gen Virol       Date:  1995-12       Impact factor: 3.891

8.  Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.

Authors:  Sameer Parekh; Fabien Zoulim; Sang Hoon Ahn; Adrienne Tsai; Jisu Li; Shigenobu Kawai; Nasser Khan; Christian Trépo; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Hepatitis B Virus e Antigen Variants.

Authors:  Shuping Tong; Kyun-Hwan Kim; Charles Chante; Jack Wands; Jisu Li
Journal:  Int J Med Sci       Date:  2005-01-05       Impact factor: 3.738

10.  Naturally occurring precore/core region mutations of hepatitis B virus genotype C related to hepatocellular carcinoma.

Authors:  Dong-Won Kim; Seoung-Ae Lee; Eung-Soo Hwang; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more
  29 in total

Review 1.  X region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Mutations in Hepatitis-B X-Gene Region: Chronic Hepatitis-B versus Cirrhosis.

Authors:  Farzaneh Salarnia; Sima Besharat; Sare Zhand; Naeme Javid; Behnaz Khodabakhshi; Abdolvahab Moradi
Journal:  J Clin Diagn Res       Date:  2017-03-01

3.  Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy.

Authors:  Elham Shirvani-Dastgerdi; Benjamin Y Winer; Toni Celià-Terrassa; Yibin Kang; David Tabernero; Eray Yagmur; Francisco Rodríguez-Frías; Josep Gregori; Tom Luedde; Christian Trautwein; Alexander Ploss; Frank Tacke
Journal:  J Hepatol       Date:  2017-04-07       Impact factor: 25.083

4.  Establishment and Characterization of an HBV Viral Spread and Infectious System following Long-Term Passage of an HBV Clinical Isolate in the Primary Human Hepatocyte and Fibroblast Coculture System.

Authors:  Yang Liu; Dmytro Kornyeyev; Lindsey May; Dong Han; Thomas Aeschbacher; Silvia Chang; Ross Martin; Hongmei Mo; Becket Feierbach
Journal:  J Virol       Date:  2022-08-29       Impact factor: 6.549

5.  Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3' End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients.

Authors:  Selene García-García; Andrea Caballero-Garralda; David Tabernero; Maria Francesca Cortese; Josep Gregori; Francisco Rodriguez-Algarra; Josep Quer; Mar Riveiro-Barciela; Maria Homs; Ariadna Rando-Segura; Beatriz Pacin-Ruiz; Marta Vila; Roser Ferrer-Costa; Tomas Pumarola; Maria Buti; Francisco Rodriguez-Frias
Journal:  Biomedicines       Date:  2022-05-21

6.  Identification of STAU1 as a regulator of HBV replication by TurboID-based proximity labeling.

Authors:  Xia-Fei Wei; Shu-Ying Fan; Yu-Wei Wang; Shan Li; Shao-Yuan Long; Chun-Yang Gan; Jie Li; Yu-Xue Sun; Lin Guo; Pei-Yun Wang; Xue Yang; Jin-Lan Wang; Jing Cui; Wen-Lu Zhang; Ai-Long Huang; Jie-Li Hu
Journal:  iScience       Date:  2022-05-18

7.  Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.

Authors:  Kuen-Nan Tsai; Chin-Liew Chong; Yu-Chi Chou; Chien-Chiao Huang; Yi-Ling Wang; Shao-Win Wang; Mong-Liang Chen; Chun-Hong Chen; Chungming Chang
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

8.  Quantitative evaluation of hepatitis B virus mutations and hepatocellular carcinoma risk: a meta-analysis of prospective studies.

Authors:  Yang Yang; Jiang-Wei Sun; Long-Gang Zhao; Freddie Bray; Yong-Bing Xiang
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

9.  Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients.

Authors:  Xiao-Ling Wang; Jian-Ping Ren; Xue-Qing Wang; Xiao-Hong Wang; Shao-Fang Yang; Yi Xiong
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

10.  MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter.

Authors:  Marwa K Ibrahim; Tawfeek H Abdelhafez; Junko S Takeuchi; Kosho Wakae; Masaya Sugiyama; Masataka Tsuge; Masahiko Ito; Koichi Watashi; Mohamed El Kassas; Takanobu Kato; Asako Murayama; Tetsuro Suzuki; Kazuaki Chayama; Kunitada Shimotohno; Masamichi Muramatsu; Hussein H Aly; Takaji Wakita
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.